🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

Recruitingn/aAges any - anyAllPusan National University Yangsan Hospital
NCT06211491 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients with chronic spinal cord injury 6 months after receiving the award 2. Patients with confirmed AD due to bladder fullness in previous urodynamic test 3. Patients confirmed to have neurological damage level C1-T6, AIS A or B Exclusion Criteria: 1. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test 2. Patients who cannot undergo testing due to hemodynamic instability 3. Patients who cannot undergo testing due to overt urinary tract infection
💊

What it tests

  • Urodynamic test
📍

Where

1 site
Pusan National University Yangsan Hospital
Yangsan, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy